Usefulness and limitations of rituximab in managing patients with lymphoproliferative disorder after heart transplantation. [electronic resource]
Producer: 20130205Description: 513-8 p. digitalISSN:- 2146-8427
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Female
- Heart Transplantation -- adverse effects
- Humans
- Immunologic Factors -- therapeutic use
- Lymphoproliferative Disorders -- drug therapy
- Male
- Middle Aged
- Postoperative Complications -- drug therapy
- Remission Induction
- Rituximab
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.